Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy
- Applicable to Encounter for antineoplastic chemotherapy and immunotherapy
- The 2025 edition of ICD10-CM Z51.1 became effective on October 1, 2024.
- This is the American ICD10-CM version of Z51.1 - other international versions of ICD10 Z51.1 may differ.
- Z51.1 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Z51.1 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy
- Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy
- Z51.11 - Encounter for antineoplastic chemotherapy
- Z51.12 - Encounter for antineoplastic immunotherapy
Type 2 Excludes
- encounter for chemotherapy and immunotherapy for nonneoplastic condition - code to condition
The following codes above Z51.1 contain annotation back-references that may be applicable to Z51.1:
Chapter: Z00-Z99 Factors influencing health status and contact with health services
Section: Z40-Z53 Encounters for other specific health care
Category: Z51 Encounter for other aftercare and medical care
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com